Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release
Abstract
The effects of nicotine on 5-hydroxytryptamine (5-HT) release from serotonergic nerve endings in rat dorsal hippocampal slices were studied. Nicotine (50-500 microM:) caused a concentration-dependent increase in 5-HT release. This effect was antagonised by mecamylamine (0.5 microM:), indicating an action at nicotinic receptors. Nicotine-evoked 5-HT release was not affected by tetrodotoxin (3 microM:), cadmium chloride (0.1 mM:), or the absence of Ca(2+) or Na(+) in the superfusion medium. Unexpectedly, higher concentrations of mecamylamine alone (1-50 microM:) increased 5-HT release. This suggested the presence of inhibitory input to 5-HT neurones and that these inhibitory neurones possess tonically active nicotinic receptors. The effect of mecamylamine (50 microM:) on 5-HT release was reduced by the muscarinic M(1) receptor agonist, McN-A-343 (100 microM:), but pirenzepine (0.005-1 microM:), which blocks M(1) receptors, alone increased 5-HT release. Hippocampal serotonergic neurones are known to possess both excitatory nicotinic receptors and inhibitory M(1) receptors. Although there may be several explanations for our results, one possible explanation is that nicotine stimulates 5-HT release by activating nicotinic heteroreceptors on 5-HT terminals. Mecamylamine (0.5 microM:) antagonises this effect, but higher concentrations increase 5-HT release indirectly by blocking the action of endogenous acetylcholine on nicotinic receptors situated on cholinergic neurones that provide muscarinic inhibitory input to 5-HT neurones.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Both nicotine and the nicotinic antagonist mecamylamine can increase serotonin release in the hippocampus.
“both nicotine and the nicotinic antagonist mecamylamine can increase serotonin release in the hippocampus (Kenny et al., 2000)”
From Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states (2015) · cites this paper as Kenny et al., 2000
Both chronic nicotine and mecamylamine can facilitate serotonin transmission in the hippocampus, while monoamine depletion effects can be partially reversed by nicotine administration and can lead to changes in anxiety-like behavior in the elevated plus maze.
“both chronic nicotine and the nicotinic antagonist mecamylamine can facilitate serotonin transmission in the hippocampus, while the effects of monoamine depletion can be partially reversed by nicotine administration and can lead to changes in anxiety-like behavior in the elevated plus maze (File et al., 2000a; File et al., 2000b; Fu et al., 1998; Kenny et al., 2000)”
From Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states (2015) · cites this paper as Kenny et al., 2000
Cites
Séguéla, P., Wadiche, J. I., Dineley‐Miller, K., Dani, J., & Jw, P. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00596.1993 · Cited by 1,471 · see citing works
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308 · see citing works
Wada, E., Wada, K., Boulter, J., Deneris, E. S., Heinemann, S., Patrick, J., & Swanson, L. W. (1989) · The Journal of Comparative Neurology · doi:10.1002/cne.902840212 · Cited by 1,044 · see citing works
Hippocampal synaptic transmission enhanced by low concentrations of nicotine
Gray, R. G. F., Rajan, A. S., Radcliffe, K. A., Yakehiro, M., & Dani, J. A. (1996) · Nature · doi:10.1038/383713a0 · Cited by 947 · see citing works
Human neuronal nicotinic receptors
Gotti, C., Fornasari, D., & Clementi, F. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00034-8 · Cited by 413 · see citing works
Neuronal Nicotinic Acetylcholine Receptors
Lindstrom, J. (1996) · Springer eBooks · doi:10.1007/978-1-4899-1775-1_10 · Cited by 382 · see citing works
Grady, S., Marks, M. J., Wonnacott, S., & Collins, A. C. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08322.x · Cited by 350 · see citing works
Alkondon, M., Pereira, E. F. R., Eisenberg, H. M., & Albuquerque, E. X. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02693.1999 · Cited by 332 · see citing works
Alkondon, M., Pereira, E. F. R., Barbosa, C. T. F., & Albuquerque, E. X. (1997) · PubMed · Cited by 326 · see citing works
Chapter 11 Cell types using glutamate as a neurotransmitter in the vertebrate retina
Massey, S. C. (1990) · Progress in Retinal Research · doi:10.1016/0278-4327(90)90013-8 · Cited by 287 · see citing works
Functional nicotinic ACh receptors on interneurones in the rat hippocampus
Jones, S., & Yakel, J. L. (1997) · The Journal of Physiology · doi:10.1111/j.1469-7793.1997.603bd.x · Cited by 271 · see citing works
Clarke, P. B. S., & Reuben, M. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15232.x · Cited by 262 · see citing works
The Role of the Dorsal Hippocampal Serotonergic and Cholinergic Systems in the Modulation of Anxiety
File, S. E., Kenny, P. J., & Cheeta, S. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00198-2 · Cited by 240 · see citing works
Self-citationTóth, E., Sershen, H. W., Hashim, A. T., Vizi, E. S., & Lajtha, Á. (1992) · Neurochemical Research · doi:10.1007/bf00966669 · Cited by 194 · see citing works
Sershen, H. W., Balla, A., Lajtha, Á., & Vizi, E. S. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00425-3 · Cited by 136 · see citing works
The Pharmacology of (-)-Nicotine and Novel Cholinergic Channel Modulators
Brioni, J. D., Decker, M. W., Sullivan, J. P., & Arnerić, S. P. (1996) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60950-3 · Cited by 134 · see citing works
Alkondon, M., Pereira, E. F. R., Barbosa, C. T. F., & Albuquerque, E. X. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37139-3 · Cited by 127 · see citing works
Araujo, D. M., Lapchak, P. A., Collier, B., & Quirion, R. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb04869.x · Cited by 121 · see citing works
Effects of nicotine and mecamylamine on rat dorsal raphe neurons
Mihailescu, S., Palomero-Rivero, M., Meade-Huerta, P., Maza-Flores, A., & Drucker-Colı́n, R. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00658-x · Cited by 117 · see citing works
O’Dell, T. J., & Christensen, B. N. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90276-5 · Cited by 111 · see citing works
Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes
Wilkie, G., Hutson, P. H., Sullivan, J. P., & Wonnacott, S. (1996) · Neurochemical Research · doi:10.1007/bf02532425 · Cited by 103 · see citing works
Rao, T. S., Correa, L. D., Reid, R. T., & Lloyd, G. K. (1996) · Neuropharmacology · doi:10.1016/0028-3908(96)00013-5 · Cited by 94 · see citing works
Nicotine-induced release of catecholamines from rat hippocampus and striatum
Arqueros, L., Naquira, D., & Zunino, E. (1978) · Biochemical Pharmacology · doi:10.1016/0006-2952(78)90040-0 · Cited by 92 · see citing works
The Molecular Biology of Neuronal Nicotinic Acetylcholine Receptors
Boyd, R. T. (1997) · Critical Reviews in Toxicology · doi:10.3109/10408449709089897 · Cited by 84 · see citing works
Nicotine-evoked [3H]5-hydroxytryptamine release from rat striatal synaptosomes
Reuben, M., & Clarke, P. B. S. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00147-1 · Cited by 84 · see citing works
Initial Characterization of the Nicotinic Acetylcholine Receptors in Rat Hippocampal Neurons
Alkondon, M., & Albuquerque, E. X. (1991) · Journal of Receptor Research · doi:10.3109/10799899109064693 · Cited by 83 · see citing works
5‐HT4 receptor‐mediated modulation of 5‐HT release in the rat hippocampus in vivo
Ge, J., & Barnes, N. M. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15309.x · Cited by 76 · see citing works
Toide, K., & Arima, T. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90510-4 · Cited by 74 · see citing works
Differential Effect of NMDA on Extracellular Serotonin in Rat Midbrain Raphe and Forebrain Sites
Tao, R., & Auerbach, S. B. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66031067.x · Cited by 70 · see citing works
Hiramatsu, M., Murasawa, H., Nabeshima, T., & Kameyama, T. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37307-0 · Cited by 64 · see citing works
Clarke, P. B. S., Chaudieu, I., El-Bizri, H., Boksa, P., Quik, M., Esplin, B. A., & Čapek, R. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14748.x · Cited by 64 · see citing works
H�ry, F., Bourgoin, S., Hamon, M., Ternaux, J., & Glowinski, J. (1977) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00508459 · Cited by 64 · see citing works
Kenny, P. J., Cheeta, S., & File, S. E. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00114-8 · Cited by 63 · see citing works
Self-citationPei, Q., Zetterström, T., & Fillenz, M. (1989) · Neuropharmacology · doi:10.1016/0028-3908(89)90118-4 · Cited by 59 · see citing works
Pittaluga, A., Bonfanti, A., & Raiteri, M. (1997) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005025 · Cited by 54 · see citing works
Lendvai, B., Sershen, H. W., Lajtha, Á., Sántha, E., Baranyi, M., & Vizi, E. S. (1996) · Neuropharmacology · doi:10.1016/s0028-3908(96)00115-3 · Cited by 52 · see citing works
Evidence for modulation of GABAergic neurotransmission by nicotine
Freun, R. K., Jungschaffer, D. A., Collins, A. C., & Wehner, J. M. (1988) · Brain Research · doi:10.1016/0006-8993(88)90160-6 · Cited by 49 · see citing works
Sacaan, A. I., Menzaghi, F., Dunlop, J. L., Correa, L. D., Whelan, K. T., & Lloyd, G. K. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12301-x · Cited by 47 · see citing works
Whitton, P. S., Richards, D. A., Biggs, C. S., & Fowler, L. J. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90395-6 · Cited by 44 · see citing works
Assié, M., & Koek, W. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15749.x · Cited by 38 · see citing works
Dual Effect of DMPP on the Resting Release of Noradrenaline from Rat Hippocampal Slices
Kiss, J., Windisch, K., Balla, A., Sershen, H. W., & Lajtha, Á. (1997) · Brain Research Bulletin · doi:10.1016/s0361-9230(96)00339-5 · Cited by 30 · see citing works
Effect of nicotine on the level of extracellular amino acids in the hippocampus of rat
Tóth, E. (1996) · Neurochemical Research · doi:10.1007/bf02532339 · Cited by 27 · see citing works
Whitton, P. S., Maione, S., Biggs, C. S., & Fowler, L. J. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90562-2 · Cited by 25 · see citing works
COURT, J. A., Piggott, M. A., & Perry, E. K. (1990) · Brain Research · doi:10.1016/0006-8993(90)90708-j · Cited by 25 · see citing works
Marchi, M., Paudice, P., Bella, M., & Raiteri, M. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90446-2 · Cited by 22 · see citing works
Davidson, C., & Stamford, J. A. (1997) · Brain Research Bulletin · doi:10.1016/s0361-9230(97)00026-9 · Cited by 12 · see citing works
Effects of muscarinic receptor agonists and antagonists on rat brain serotonergic activity
Bhattacharya, S. K., & Sen, A. P. (1992) · Journal of Neural Transmission · doi:10.1007/bf01250965 · Cited by 9 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 549 · see citing works
PICCIOTTO, M., ADDY, N., MINEUR, Y., & BRUNZELL, D. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.12.005 · Cited by 451 · see citing works
Cholinesterase Inhibitors Used in the Treatment of Alzheimer???s Disease
Wilkinson, D. G., Francis, P. T., Schwam, E. M., & Payne-Parrish, J. (2004) · Drugs & Aging · doi:10.2165/00002512-200421070-00004 · Cited by 365 · see citing works
Neurobiology of the nicotine withdrawal syndrome
Kenny, P. J., & Markou, A. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00651-7 · Cited by 310 · see citing works
Self-citationNicotine receptors and depression: revisiting and revising the cholinergic hypothesis
Mineur, Y. S., & Picciotto, M. R. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.09.004 · Cited by 277 · see citing works
Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics
Dulawa, S. C., & Janowsky, D. S. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0219-x · Cited by 187 · see citing works
Beyond the Cholinergic Hypothesis: Do Current Drugs Work in Alzheimer's Disease?
Martorana, A., Esposito, Z., & Koch, G. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00175.x · Cited by 174 · see citing works
Kenny, P. J., File, S. E., & Rattray, M. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00246-1 · Cited by 165 · see citing works
Self-citationPicciotto, M. R., Lewis, A. S., van Schalkwyk, G. I., & Mineur, Y. S. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.028 · Cited by 157 · see citing works
Nicotinic–serotonergic interactions in brain and behaviour
Seth, P., Cheeta, S., Tucci, S., & File, S. E. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00715-8 · Cited by 145 · see citing works
Self-citationDesensitization of nicotinic acetylcholine receptors as a strategy for drug development
Buccafusco, J. J., Beach, J. W., & Terry, A. V. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145292 · Cited by 144 · see citing works
Fowler, C. D., Arends, M. A., & Kenny, P. J. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c360e · Cited by 131 · see citing works
Self-citationCaldarone, B. J., Harrist, A., Cleary, M. A., Beech, R. D., King, S. L., & Picciotto, M. R. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.010 · Cited by 122 · see citing works
Cholinergic connectivity: it's implications for psychiatric disorders
Scarr, E., Gibbons, A. S., Neo, J. H., Udawela, M., & Dean, B. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00055 · Cited by 117 · see citing works
Christensen, R., Marcussen, A. B., Wörtwein, G., Knudsen, G. M., & Aznar, S. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.10.009 · Cited by 109 · see citing works
Nicotine and cannabinoids: parallels, contrasts and interactions
VIVEROS, M., MARCO, E., & FILE, S. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.08.002 · Cited by 106 · see citing works
Self-citationAndreasen, J., Olsen, G., Wiborg, O., & Redrobe, J. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108091587 · Cited by 101 · see citing works
Lechín, F., van der Dijs, B., & Hernández-Adrián, G. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.11.025 · Cited by 101 · see citing works
Bacher, I., Wu, B., Shytle, D. R., & George, T. P. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903329102 · Cited by 96 · see citing works
Jamal, M., van der Does, W. A. J., Elzinga, B. M., Molendijk, M. L., & Penninx, B. W. J. H. (2014) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntu151 · Cited by 83 · see citing works
Andreasen, J. T., & Redrobe, J. P. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832c713e · Cited by 82 · see citing works
Popik, P., Kozela, E., & Krawczyk, M. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705359 · Cited by 74 · see citing works
Kulak, J. M., McIntosh, J. M., Yoshikami, D., & Olivera, B. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00357.x · Cited by 73 · see citing works
Rao, T. S., Correa, L. D., Adams, P. B., Santori, E. M., & Sacaan, A. I. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03532-7 · Cited by 71 · see citing works
Nicotine regulates 5‐HT1A receptor gene expression in the cerebral cortex and dorsal hippocampus
Kenny, P. J., File, S. E., & Rattray, M. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01501.x · Cited by 63 · see citing works
Self-citationNeurochemical alterations produced by daily nicotine exposure in periadolescent vs. adult male rats
Collins, S. L., Wade, D., Ledon, J., & Izenwasser, S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.08.039 · Cited by 62 · see citing works
Tucci, S. A., Genn, R. F., & File, S. E. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(02)00391-x · Cited by 59 · see citing works
Self-citationRole of the endogenous cannabinoid system in nicotine addiction: novel insights
Gamaleddin, I. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00041 · Cited by 58 · see citing works
Aboul‐Fotouh, S. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3745-5 · Cited by 53 · see citing works
Biological basis for the co-morbidity between smoking and mood disorders
Mineur, Y. S., & Picciotto, M. R. (2009) · Journal of Dual Diagnosis · doi:10.1080/15504260902869964 · Cited by 51 · see citing works
Prefrontal neuromodulation by nicotinic receptors for cognitive processes
Coura, R., & Granon, S. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2596-6 · Cited by 51 · see citing works
Cheeta, S., Kenny, P. J., & File, S. E. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00246.x · Cited by 50 · see citing works
Self-citationDecreased anxiety-like behavior in beta3 nicotinic receptor subunit knockout mice
Booker, T. K., Butt, C. M., Wehner, J. M., Heinemann, S. F., & Collins, A. C. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.04.011 · Cited by 49 · see citing works
Caldarone, B. J., Wang, D., Paterson, N. E., Manzano, M., Fedolak, A., Cavino, K., Kwan, M., Hanania, T., Chellappan, S. K., Kozikowski, A. P., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2271-y · Cited by 47 · see citing works
Andreasen, J. T., & Redrobe, J. P. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.08.016 · Cited by 47 · see citing works
Viveros, M., Marco, E. M., Llorente, R., & Lamota, L. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282d28fb4 · Cited by 44 · see citing works
Andreasen, J. T., Redrobe, J. P., & Nielsen, E. Ø. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.11.004 · Cited by 43 · see citing works
Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats
Levin, E. D., Slade, S. K., Johnson, M., Petro, A. E., Horton, K., Williams, P., Rezvani, A. H., & Rose, J. E. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.016 · Cited by 43 · see citing works
Effects of acute and chronic nicotine on elevated plus maze in mice: Involvement of calcium channels
Biała, G., & Budzyńska, B. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.043 · Cited by 43 · see citing works
Siegel, J. A., Craytor, M. J., & Raber, J. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833e7e44 · Cited by 42 · see citing works
Andreasen, J. T., Nielsen, E. Ø., Christensen, J. K., Olsen, G. M., Peters, D., Mirza, N. R., & Redrobe, J. P. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110364271 · Cited by 38 · see citing works
Gould, R. W., Czoty, P. W., Nader, S. H., & Nader, M. A. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.185538 · Cited by 37 · see citing works
Mineur, Y. S., Einstein, E. B., Bentham, M. P., Wigestrand, M. B., Blakeman, S., Newbold, S. A., & Picciotto, M. R. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.269 · Cited by 33 · see citing works
Smythies, J. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)64005-6 · Cited by 32 · see citing works
Section I. The Cholinergic System
Smythies, J. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)64001-9 · Cited by 32 · see citing works
α7 nicotinic receptor subunit is present on serotonin neurons projecting to hippocampus and septum
Aznar, S., Kostova, V., Christiansen, S. H., & Knudsen, G. M. (2005) · Synapse · doi:10.1002/syn.20108 · Cited by 31 · see citing works
Nicotine augmentation for refractory obsessive-compulsive disorder. A case report
Pasquini, M., Garavini, A., & Biondi, M. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.08.011 · Cited by 31 · see citing works
Smoking, parent smoking, depressed mood, and suicidal ideation in teens
Hockenberry, J. M., Timmons, E. J., & Weg, M. W. V. (2010) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp199 · Cited by 27 · see citing works
Wang, S., Yabuki, Y., Matsuo, K., Xu, J., Izumi, H., Sakimura, K., Saito, T., Saido, T. C., & Fukunaga, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206986 · Cited by 26 · see citing works
Dietary Restriction and Nicotine can Reduce Anxiety in Female Rats
Genn, R. F., Tucci, S. A., Edwards, J. E., & File, S. E. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300168 · Cited by 26 · see citing works
Self-citationRoni, M. A., & Rahman, S. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.10.006 · Cited by 24 · see citing works
Fernandez, F., Aguerre, S., Mormède, P., & Chaouloff, F. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02110.x · Cited by 22 · see citing works
Development of tolerance to nicotine’s anxiogenic effect in the social interaction test
Irvine, E. E., Cheeta, S., & File, S. E. (2001) · Brain Research · doi:10.1016/s0006-8993(01)01984-9 · Cited by 22 · see citing works
Self-citationAndreasen, J. T., Nielsen, E. Ø., & Redrobe, J. P. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1560-1 · Cited by 21 · see citing works
Bhatti, A. S., Aydin, C., Oztan, O., Ma, Z., Hall, P., Tao, R., & Isgor, C. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1366-6 · Cited by 21 · see citing works
Nicotinic mechanisms contribute to soman-induced symptoms and lethality
Hassel, B. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.01.007 · Cited by 21 · see citing works
Hansen, C. P., Jensen, A. A., Christensen, J. K., Balle, T., Liljefors, T., & Frølund, B. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701625v · Cited by 21 · see citing works
Roni, M. A., & Rahman, S. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.10.009 · Cited by 19 · see citing works
Nasehi, M., Mohammadi-Mahdiabadi-Hasani, M.-H., Ebrahimi-Ghiri, M., & Zarrindast, M. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05294-0 · Cited by 18 · see citing works
Martínez-Ortega, J. M., Goldstein, B. I., Gutiérrez-Rojas, L., Sala, R., Wang, S., & Blanco, C. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.03.012 · Cited by 17 · see citing works
Rorabaugh, B. R., Sprague, L., Norman, H., Seeley, S. L., & D’Souza, M. S. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14100 · Cited by 16 · see citing works
Alpha-7 and alpha-4 nicotinic receptor subunit immunoreactivity in genioglossus muscle motoneurons
Dehkordi, O., Millis, R. M., Dennis, G. C., Coleman, B. R., Johnson, S. M., Changizi, L., & Trouth, C. O. (2005) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2004.09.003 · Cited by 16 · see citing works
Wang, T., Moon, J., Wu, Y., Amos, C. I., Hung, R. J., Tardón, A., Andrew, A. S., Chen, C., Christiani, D. C., Albanes, D., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185660 · Cited by 16 · see citing works
O'Connor, S. M., Sleebs, B. E., Street, I. P., Flynn, B. L., Baell, J. B., Coles, C., Quazi, N., Paul, D., Poiraud, E., Huyard, B., et al. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109836 · Cited by 15 · see citing works
Functional Connectivity of the Raphe Nuclei: Link to Tobacco Withdrawal in Smokers
Faulkner, P., Ghahremani, D. G., Tyndale, R. F., Hellemann, G., & London, E. D. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy054 · Cited by 15 · see citing works
Hamurtekin, E., Bağdaş, D., & Gurun, M. S. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.04.058 · Cited by 14 · see citing works
Carrier-mediated release of monoamines induced by the nicotinic acetylcholine receptor agonist DMPP
Szász, B. K., MAYER, A., Zsilla, G., Lendvai, B., Vizi, E. S., & Kiss, J. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.03.023 · Cited by 13 · see citing works
Age-dependent effects of initial exposure to nicotine on serotonin neurons
Bang, S. J., & Commons, K. G. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.01.032 · Cited by 12 · see citing works
Kolisnyk, B., Al‐Onaizi, M., Prado, V. F., & Prado, M. A. M. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13260 · Cited by 12 · see citing works
Kumari, A., Sreetama, S. C., & Mohanakumar, K. P. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.06.027 · Cited by 11 · see citing works
Wooters, T. E., & Bardo, M. T. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1487-6 · Cited by 11 · see citing works
Kornum, B. R., Weikop, P., Møller, A., Rønn, L. C. B., Knudsen, G. M., & Aznar, S. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.030 · Cited by 11 · see citing works
Temporal sequencing of nicotine dependence and major depressive disorder: A U.S. national study
Martínez-Ortega, J. M., Franco, S., Rodríguez-Fernández, J. M., Gutiérrez-Rojas, L., Wang, S., & Manuel Gurpegui, A. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.01.087 · Cited by 9 · see citing works
Khadrawy, Y. A., El-Shamy, K. A., & Mohamed, S. (2011) · PubMed · Cited by 9 · see citing works
Nirogi, R. V. S., Abraham, R., Jayarajan, P., Goura, V., Kallepalli, R., Medapati, R. B., Tadiparthi, J., Goyal, V., Pandey, S. K., Subramanian, R., et al. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06108-6 · Cited by 8 · see citing works
Role of Central Serotonin Receptors in Nicotine Addiction
Pierucci, M., Chambers, S., Partridge, L., Deurwaerdère, P. D., & Giovanni, G. D. (2014) · The Receptors · doi:10.1007/978-1-4939-1167-7_14 · Cited by 8 · see citing works
Efficacy of nicotine administration on obsessions and compulsions in OCD: a systematic review
Piacentino, D., Maraone, A., Roselli, V., Berardelli, I., Biondi, M., Kotzalidis, G. D., & Pasquini, M. (2020) · Annals of General Psychiatry · doi:10.1186/s12991-020-00309-z · Cited by 8 · see citing works
Ma, Z., Pearson, E. J., Isgor, C., & Tao, R. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.080 · Cited by 8 · see citing works
Severino, M., Pedersen, A. F., Trajkovska, V., Christensen, E. M., Lohals, R., Veng, L., Knudsen, G. M., & Aznar, S. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.09.026 · Cited by 7 · see citing works
Rivastigmine Restores 5-HT1A Receptor Levels in the Hippocampus of Olfactory Bulbectomized Mice
Islam, M. R., Moriguchi, S., Tagashira, H., & Fukunaga, K. (2014) · Advances in Alzheimer s Disease · doi:10.4236/aad.2014.33012 · Cited by 6 · see citing works
Yu, J. (2010) · The Open Behavioral Science Journal · doi:10.2174/1874230001004010009 · Cited by 6 · see citing works
The Etiology and Treatment of Nicotine Dependence: A Biopsychosocial Perspective
Cohen, L. M., McChargue, D. E., Cortez-Garland, M., Prensky, E. H., & Emery, S. K. (2003) · Sage eBooks · doi:10.4135/9781412976770.n7 · Cited by 6 · see citing works
Mechanisms of stimulatory effects of mecamylamine on the dorsal raphe neurons
Hernández-González, O., Mondragón-García, A., Hernández‐López, S., Castillo-Rolón, D., Arenas-López, G., Tapia, D., & Mihailescu, S. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.08.031 · Cited by 5 · see citing works
Soria-Fregozo, C., Flores-Soto, M. E., Vega, M. I. P., & Feria‐Velasco, A. (2013) · Neurología (English Edition) · doi:10.1016/j.nrleng.2012.04.012 · Cited by 5 · see citing works
Hansen, C. P., Jensen, A. A., Balle, T., Bitsch-Jensen, K., Hassan, M. M., Liljefors, T., & Frølund, B. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.11.011 · Cited by 4 · see citing works
Soria-Fregozo, C., Flores-Soto, M. E., Vega, M. I. P., & Feria‐Velasco, A. (2012) · Neurología · doi:10.1016/j.nrl.2012.04.002 · Cited by 4 · see citing works
Blockade of cholinergic transmission elicits somatic signs in nicotine-naïve adolescent rats
Schmidt, C. E., Manbeck, K. E., Shelley, D., & Harris, A. C. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00239 · Cited by 4 · see citing works
Khakpai, F., & Zarrindast, M. (2023) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2023-017 · Cited by 4 · see citing works
(2016) · Neurotransmitter · doi:10.14800/nt.1293 · Cited by 4 · see citing works
Harris, A. C. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173185 · Cited by 3 · see citing works
Central cholinergic transmission affects the compulsive-like behavior of mice in marble-burying test
Patel, C., Patel, R., Maturkar, V., & Jain, N. S. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148713 · Cited by 2 · see citing works
Cadmium Increases the Sensitivity of Adolescent Female Mice to Nicotine-Related Behavioral Deficits
Adeniyi, P. A., Olatunji, B. P., Ishola, A. O., Ajonijebu, D. C., & Ogundele, O. M. (2014) · Behavioural Neurology · doi:10.1155/2014/360978 · Cited by 2 · see citing works
Kim, E. A., Jung, K. C., Sohn, U. D., & Im, C. (2009) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2009.13.1.55 · Cited by 1 · see citing works
The Cannabinoid System in Nicotine Dependence and Withdrawal
McIlwain, M., Minassian, A., & Perry, W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802574-1.00009-0 · Cited by 1 · see citing works
Effect of Smoking Index on Cardiovascular System in Some Libyans
(2017) · ARC Journal of Forensic Science · doi:10.20431/2456-0049.0201002
남성 우울증 환자에서 흡연 유무에 따른 Loudness Dependence of the Auditory Evoked Potential의 차이
양은경, 김진환, & Lee, S. H. (2011) · 대한정신약물학회지
Faulkner, P., Knudsen, G. M., Frøkjær, V. G., & Erritzøe, D. (2025) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaf026
- Authors
- Kenny, P. J., File, S. E., & Neal, M. J.
- Affiliations
- King's College London (GB)
- ORCID
- Kenny, Paul J.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2000-12
- Volume
- 75
- Issue
- 6
- Pages
- 2409-2414
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2029619668
- Cited by
- 100
- References
- 48
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 4 · 2017: 3 · 2016: 2 · 2015: 5 · 2014: 7 · 2013: 3 · 2012: 2
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, serotonin release, hippocampus, mecamylamine, M1 muscarinic receptor, McN-A-343, pirenzepine, serotonergic neurons, cholinergic modulation, inhibitory interneurons, nicotine
- MeSH terms
- Animals, Calcium, Calcium Channel Blockers, Carrier Proteins, Dose-Response Relationship, Drug, Hippocampus, Male, Mecamylamine, Membrane Glycoproteins, Nerve Tissue Proteins, Nicotine, Rats, Inbred Strains, Receptors, GABA-A, Receptors, Muscarinic, Receptors, Nicotinic, Serotonin, Tetrodotoxin, Selective Serotonin Reuptake Inhibitors, Paroxetine, Receptors, Glutamate, Nicotinic Agonists, Nicotinic Antagonists, Membrane Transport Proteins, Receptor, Muscarinic M1, Serotonin Plasma Membrane Transport Proteins, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review